Lindus Health completes $55m funding round
Self-described anti-clinical research organisation (CRO) Lindus Health has received $55m in Series B funding to back its fully integrated, AI-driven …
Post
-
-
Rigel enrols first subject in Phase I sickle cell disease therapy trial
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, …
-
Tris Pharma reports positive data from Phase III acute pain therapy trial
Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain …
-
Interim data success for Salubris Biotherapeutics’ heart failure candidate
US company Salubris Biotherapeutics (SalubrisBio) has seen its heart failure therapy, JK07, achieve some success in interim results taken from …
-
Sonnet BioTherapeutics to expand trial of SON-1010 with trabectedin for solid tumours
US-based biotechnology company Sonnet BioTherapeutics has expanded its Phase I SB101 study of SON-1010 for advanced solid tumours. The company is …
-
Exact Sciences post positive results from MRD trial
Exact Sciences, has shared results from a trial of its Oncodetect test which is designed to identify the last remaining …
-
Advarra introduces Study Collaboration to help improve trial partnership
US-based clinical research company Advarra has introduced Study Collaboration, a solution designed to expedite study startup by automating workflows. The solution …
-
The next stage of DCTs: New survey sheds light on how to move forward with mobile visits
Mobile research models are making a positive difference in clinical research, helping drug sponsors bring studies to patient populations that …
-
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's …
-
How biotechs can recover VAT on EU-based clinical trials
At a time when companies are managing more expensive clinical trials with less funding, any opportunity to reduce trial costs …
-
FDA lifts clinical hold on Amylyx’s Phase I ALS trial
The US Food and Drug Administration (FDA) has lifted a clinical hold on Amylyx Pharmaceuticals’ Phase I trial of AMX0114 …
-
PFAS in drinking water linked with increased incidence of cancer in the US
Synthetic chemicals called per- and polyfluoroalkyl substances (PFAS) have been accumulating in the environment since their introduction in the 1940s, …
-
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry
Leading lead generation providers and technology solutions for the clinical trials industry: Introduction The clinical trials sector is a critical component …
-
Pulse Biosciences touts positive results from PFA early feasibility study
Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for …
-
Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial
Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending dose (SAD) study of the oral …
